An open label, phase I study evaluating the effects of ABP-700 in combination with fentanyl and remifentanil, on electrocardiogram parameters of conduction and repolarization during infusions targeted to produce hypnosis.
Phase of Trial: Phase I
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Cyclopropyl-methoxycarbonylmetomidate (Primary)
- Indications Anaesthesia
- Focus Adverse reactions
- 02 Jan 2017 New trial record